U2AF2 p.Ser32Pro
c.94T>C · VCV3464856
Computational evidence
| Protein change | ||
| AlphaMissense | 0.3942 | ambiguous |
|---|---|---|
| REVEL | 0.058 | moderately benign-leaning |
| SaProt | LLR -11.31 | damaging |
| ⇒ SaProt calls this damaging; REVEL does not; AlphaMissense is indeterminate. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 4.9 | GERP 1.4, phastCons 1 |
| Regional constraint | o/e 0.69 | unconstrained · MANE · 5,440 bp · p 0.00024 · regional, not allelic |
| Overall | ||
| CADD | 26.8 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- U2AF2
- Protein
- p.Ser32Pro
- Coding
- c.94T>C
- MANE Select
- NM_007279
- Type
- single nucleotide variant
- Location
- chr19:55659254 (GRCh38)
- Gene constraint
- LOEUF 0.209 · pLI 1.00 (gnomAD)
- Structure
- AlphaFold pLDDT 73.24 · 40 PDB
- Residue 32
- the 'disordered' region; the 'required for interaction with prpf19' region; the 'necessary and sufficient to stimulate pre-mrnas 3'-end cleavage in a cfim complex-dependent manner' region
Similar variants
- U2AF2 p.Arg149Trp Pathogenic ★★ same condition
- U2AF2 p.His470Gln Uncertain significance ★★ ⚠ same condition
- U2AF2 p.Arg37His Uncertain significance ★ ⚠ same condition
- U2AF2 p.Arg40Gln Uncertain significance ★ ⚠ same condition
- U2AF2 p.Arg40Trp Uncertain significance ★ ⚠ same condition
- U2AF2 p.Arg47His Uncertain significance ★ ⚠ same condition
- U2AF2 p.Arg49Gln Uncertain significance ★ ⚠ same condition
- U2AF2 p.Arg61His Uncertain significance ★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/u2af2-p-ser32pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown